TENKTenX Keane Acquisition

Nasdaq N/A


$ 1.64 $ 0.00 (0 %)    

Monday, 16-Sep-2024 14:39:22 EDT
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 1.63
$ 1.65
$ 1.64 x 100
-- x --
$ 1.64 - $ 1.65
$ 1.53 - $ 49.00
67,396
na
191.95M
$ -0.03
$ 83.55
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-09-2024 06-30-2024 10-Q
2 05-20-2024 03-31-2024 10-Q
3 04-16-2024 12-31-2023 10-K
4 11-20-2023 09-30-2023 10-Q
5 08-16-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 04-17-2023 12-31-2022 10-K
8 11-28-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Citius Pharmaceuticals to receive 65.6 million shares of TenX Keane, which will be renamed Citius Oncology, Inc.Citius Pharmace...

Core News & Articles

TenX Keane Acquisition (the "Company") (NASDAQ:TENKU) today announced that, in order to extend the date by which the Co...

Core News & Articles

TenX Keane Acquisition (the "Company") (NASDAQ:TENKU) today announced that, in order to extend the date by which the Co...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION